Page last updated: 2024-09-05

ahc 52 and Leukemia P388

ahc 52 has been researched along with Leukemia P388 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebisu, H; Inaba, M; Mitsuhashi, J; Shinoda, H; Tsuruo, T1
Inaba, M; Shinoda, H; Tsuruo, T1

Other Studies

2 other study(ies) available for ahc 52 and Leukemia P388

ArticleYear
Therapeutic efficacy of combination of antitumor agent with AHC-52 against multidrug-resistant cells in the intravenously inoculated P388 leukemia model.
    Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dihydropyridines; Doxorubicin; Drug Resistance; Drug Synergism; Etoposide; Female; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Pyrazoles; Vincristine

1992
In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.
    Cancer research, 1989, Apr-01, Volume: 49, Issue:7

    Topics: Animals; Dihydropyridines; Drug Resistance; Drug Synergism; Female; Leukemia P388; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Nifedipine; Pyrazoles; Vincristine

1989